Stempoint Capital’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-21,052	Closed	-$2.33M	–	64
2025 Q1	$2.33M	Buy	+21,052	New	+$2.33M	0.74%	32
2024 Q1	–	Sell	-22,500	Closed	-$2.96M	–	66
2023 Q4	$2.96M	Buy	+22,500	New	+$2.96M	0.79%	40